PFA

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.1%Reaction day

₹98.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%+7.6% vs market

Medical Equipment & Supplies peers, median of 13sector-1.6%+7.7% vs sector

On the reaction day the stock moved 7.6 pts more than Nifty Microcap 250 and 7.7 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.1-1.5+7.6-1.6+7.7

Next day

+0.0-2.2+2.2-1.3+1.3

+2.0-1.2+3.3-0.7+2.7

+2.0-0.9+3.0-0.5+2.6

—-2.3—-2.6—

-3.3-2.5-0.8-2.6-0.6

-10.2-3.6-6.6-3.7-6.5

15d

—-10.4—-9.9—

+9.2-11.3+20.5-9.4+18.6

-2.2-3.6+1.3-5.4+3.1

-0.5+3.9-4.4-4.2+3.7

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Directors of Centenial Surgical Suture Ltd met on February 12, 2026, and approved the Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2025, under Regulation 33 of SEBI (LODR) Regulations, 2015. The meeting commenced at 6:30 p.m. and concluded at 6:50 p.m. The filing was signed by Mahima Bathwal, Company Secretary & Compliance Officer. The actual financial numbers are not included in this cover-letter filing and would have been attached separately.

Likely market impact

This is a routine regulatory filing confirming the timely approval of Q3 FY26 results. Shareholders should look at the separately filed financial results for actual performance metrics. No material strategic or governance decisions were announced in this filing.